ChitogenX Inc.
CHNXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$627.63K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $627,628.00 |
|---|---|
| Enterprise Value | $4.81 Million |
| Earnings per Share | $-0.02 |
| Beta | -2.09 |
| Outstanding Shares | 83,129,520 |
Return
| Return on Equity | 21.10% |
|---|---|
| Return on Assets | -403.64% |
| Return on Invested Capital | 17.24% |
Valuation & Multiples
| P/E Ratio | -0.23 |
|---|---|
| PEG | 1.03 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.85 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.88 |
| Debt to Equity | -0.57 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 5, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
December 21, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About ChitogenX Inc.
5 employees
CEO: Pierre Laurin
ChitogenX Inc. is a biologics firm focused on orthopedic and sports medicine, committing its efforts to pioneering novel soft tissue repair technologies. The company's primary objective is to elevate the efficacy of sports medicine surgi...